User profiles for Katherine M. Powell
Katherine Moore PowellTechnical Director, NOAA (affiliate Lynker) / Assoc. Scientist, Field Museum Verified email at noaa.gov Cited by 14 |
Design of a multifunctional compliant instrument for minimally invasive surgery
MI Frecker, KM Powell, R Haluck - 2005 - asmedigitalcollection.asme.org
A new multifunctional compliant instrument has been designed for use in minimally invasive
surgery. The instrument combines scissors and forceps into a single multifunctional device. …
surgery. The instrument combines scissors and forceps into a single multifunctional device. …
Effects of Raloxifene and tibial loading on bone mass and mechanics in male and female mice
…, J Hatch, AN Pulliam, KM Powell, M Hinton… - Connective tissue …, 2022 - Taylor & Francis
Purpose: Raloxifene (RAL) is a selective estrogen receptor modulator (SERM) that has
previously been shown to cause acellular benefits to bone tissue. Due to these improvements, …
previously been shown to cause acellular benefits to bone tissue. Due to these improvements, …
[HTML][HTML] Mechanical suppression of breast cancer cell invasion and paracrine signaling to osteoclasts requires nucleo-cytoskeletal connectivity
Exercise benefits the musculoskeletal system and reduces the effects of cancer. The effects
of exercise are multifactorial, where metabolic changes and tissue adaptation influence …
of exercise are multifactorial, where metabolic changes and tissue adaptation influence …
Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone
Current interventions to reduce skeletal fragility are insufficient at enhancing both the
quantity and quality of bone when attempting to improve overall mechanical integrity. …
quantity and quality of bone when attempting to improve overall mechanical integrity. …
[HTML][HTML] 6′-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor binding
KM Powell, AP Brown, CG Skaggs, AN Pulliam… - Bone reports, 2020 - Elsevier
Raloxifene (RAL) is an FDA-approved drug used to treat osteoporosis in postmenopausal
women. RAL suppresses bone loss primarily through its role as a selective estrogen receptor …
women. RAL suppresses bone loss primarily through its role as a selective estrogen receptor …
Method for optimization of a nonlinear static balance mechanism with application to ophthalmic surgical forceps
KM Powell, MI Frecker - … Technical Conferences and …, 2005 - asmedigitalcollection.asme.org
A new method for optimizing the dimensions of a nonlinear static balance mechanism has
been created. A rigid link slider-crank mechanism with a nonlinear spring is designed to …
been created. A rigid link slider-crank mechanism with a nonlinear spring is designed to …
Templated synthesis of tailored clays (based on sol-gel techniques) to yield increased pore volumes for sorption and exchange
KM Powell, RCT Slade, NI Ward - Journal of sol-gel science and …, 2004 - Springer
Synthesis and modification of Laponite-related materials by surfactants and globular cations,
leading to increased pore volume and enhanced specific surface area, is reported. …
leading to increased pore volume and enhanced specific surface area, is reported. …
Mechanical Suppression of Breast Cancer Cell Invasion and Paracrine Signaling Requires Nucleo-Cytoskeletal Connectivity
Exercise benefits the musculoskeletal system and reduces the effects of cancer. The beneficial
effects of exercise are multifactorial, where metabolic changes and tissue adaptation …
effects of exercise are multifactorial, where metabolic changes and tissue adaptation …
[BOOK][B] Templated synthesis of tailored clays to yield increased pore volumes for sorption and exchange
KM Powell - 2005 - search.proquest.com
The study aimed to enhance the textural properties of the synthetic hectorite clay Laponite
RD. In the early 1990s Mobil Research and Development Corporation produced the first …
RD. In the early 1990s Mobil Research and Development Corporation produced the first …
[HTML][HTML] Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer
…, KM Moxley, YM Kim, MA Powell… - … England Journal of …, 2019 - Mass Medical Soc
Background Stage III or IVA endometrial cancer carries a significant risk of systemic and
locoregional recurrence. Methods In this randomized phase 3 trial, we tested whether 6 months …
locoregional recurrence. Methods In this randomized phase 3 trial, we tested whether 6 months …